title: Keeping new antifungals as second-line agents only.
authors.forename: Wil
authors.initials: W
authors.lastname: van der Reijden
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D025141:Drug Resistance, Fungal; D006801:Humans; D009894:Opportunistic Infections / Q000188:drug therapy; D013045:Species Specificity
chemical_list: D000935:Antifungal Agents